Results

Total Results: 1,220 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

  1. effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/key-questions-1-does-routine-preoperative-testing-compared-to-no-testing-or-alternative-testing-strategies-improve-outcomes-such-as-surgical-complications-other-morbidity-and-mortality-among-patients-undergoing-elective-surg
    November 01, 2017 - tests change patient management decisions? … What patients or group(s) of patients does your question apply to? … safety,1 eliminate delays,15 limit harm from unnecessary follow-up of abnormal tests,7,14 improve system … safety,1 eliminate delays,15 limit harm from unnecessary follow-up of abnormal tests,7,14 improve system … This topic impacts all pre-surgical patients.
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
    November 01, 2017 - arrest, function, quality of life, other clinical sequelae of opioid overdose; health care utilization indicators … National Highway Traffic Safety Administration. The national EMS scope of practice model. … Joint meeting of the anesthetic and analgesic drug products and the drug safety and risk management … Joint meeting of anesthetic and analgesic drug products advisory committee and drug safety and risk … Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular
  3. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
    October 01, 2011 - We also included studies that report safety in patients with rheumatoid arthritis or who were taking … ), diclofenac (10/100 patient-years), and ibuprofen (11/100 patient-years). … disease prevention, usually at lower prophylactic doses GI harms: A systematic review of individual patient … though diclofenac was associated with the highest rate of hepatic laboratory abnormalities (78/1000 patient … - years, vs. 16 to 28/1000 patient-years for the other NSAIDs).
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rfviia.pptx
    May 01, 2010 - The talk will cover the current evidence on the effectiveness and safety of using recombinant activated … Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the … Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation … Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation … Safety is defined via thromboembolic events and mortality, but individual studies often lack the statistical
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/rfviia.pptx
    May 01, 2010 - The talk will cover the current evidence on the effectiveness and safety of using recombinant activated … Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the … Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation … Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation … Safety is defined via thromboembolic events and mortality, but individual studies often lack the statistical
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/musculoskeletal-disorders-imaging_research-protocol.pdf
    August 05, 2010 - Evidence-based Practice Center Technical Brief Protocol Project Title: Technical Brief - Use and Safety … It requires that the patient be placed in a tube lying flat, either prone or supine. … What are the potential safety issues and harms of positional MRI technologies? … i Types of patients/patient selection criteria: inclusion and exclusion criteria, characteristics of … enrolled patients (demographics, disease spectrum).
  7. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
    September 01, 2011 - are made in the report, its conclusions should have clinical applicability because they laid out the safety … Objective outcomes addressed include esophagitis healing, ambulatory pH, other indicators of reflux, … placebo in improving asthma symptoms, nocturnal asthma, or use of asthma medications, or in objective indicators … Administrative databases can provide additional data for addressing long-term safety issues. … Objective outcomes addressed include esophagitis healing, ambulatory pH, other indicators of reflux,
  8. Obesity (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
    July 01, 2013 - safety evaluation. … , thus disrupting the current health care model for this patient population. … data and postmarket safety evaluation—set forth by FDA. … data and postmarket safety evaluation—set forth by FDA. … would view lorcaserin if it demonstrates safety and efficacy in a majority of patients.
  9. Obesity (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - of administration would be unlikely to deter liraglutide use if it demonstrates safety and efficacy … Duo positively if it demonstrates safety and efficacy in clinical trials. … , thus disrupting the current health care model for this patient population. … data and postmarket safety evaluation—set forth by FDA. … if it demonstrates both short- and long-term safety and efficacy in a majority of patients.
  10. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ischemic-stroke-treatment_executive.pdf
    January 01, 2011 - report: author identification, year of publication, study design characteristics, study population, patient … different types of neurothrombectomy devices, what are the type(s) of devices, study designs and sizes, patientpatient discharge. … We did not draw conclusions regarding their effectiveness or safety. … the topic, including randomized controlled trials to determine the optimal device(s) to use, and the patient
  11. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - abuse by increasing the perceived safety of a harmful behavior. … Commercial clients pay annual licensing fees for CaringTXT, prorated on projected patient populations … CaringTXT annual licenses cost about $12,000 to $18,000 for an average-sized university or college client … Across all client types, patients pay for text messages only if the service is not included in their … As of June 2015, CaringTXT was in use by clients including the University of Pittsburgh and the Central
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
    June 16, 2010 - The 2006 CER revealed safety concerns for the erythropoietic stimulants as a class. … In an individual patient data meta-analysis of 13,933 patients in 53 trials treated with epoetin alfa … analyzed individual patient data from 2,122 patients in 6 trials receiving darbepoetin alpha finding … Study and Independent Patient Level Meta-Analysis Selection: Results from study- and patient-level meta-analysis … Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data
  13. Obesity (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - were uncertain regarding long-term safety and efficacy. … The yearly cost per patient would be about $13,000 at current pricing. … , which has yet to be established in this patient population. … declining because of safety concerns. … for similar reasons, but mentioned long-term safety as a concern.
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_technical-brief.pdf
    March 01, 2015 - organization that provides online information about health care quality and patient safety for consumers … http://www.cthosp.org/advocacy/quality-and-patient-safety/hospital-quality- reporting-website/ RWJF … a=3132&q=388090 http://www.cthosp.org/advocacy/quality-and-patient-safety/hospital-quality-reporting-website … / http://www.cthosp.org/advocacy/quality-and-patient-safety/hospital-quality-reporting-website/ http: … http://www.sts.org/quality-research-patient-safety/sts-public-reporting-online RWJF Excluded 214.
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-1-year-final-report-updated-title_0.pdf
    May 01, 2024 - Director, General Patient Safety Program Center for Quality Improvement and Patient Safety Agency … effectiveness of patient safety practices (PSPs). … safety progress,”7 a claim supported by a recent meta- analysis indicating that as many as 1 in 20 patients … the purpose of improving patient safety. … safety practices Patient Safety Practice Summary of Final Advice Categorization of Final Advice 1
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar_research.pdf
    August 01, 2015 - Patient Stakeholder Baltimore, MD Ruth Horowitz, M.D. … Study design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention … Study design: Endpoint Classification: Safety Study Intervention Model: Single Group Assignment … Study design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention … Study design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
    October 01, 2010 - . ��� Increased risk for arterial thromboembolic events, particularly at doses >40 µg/kg of patient … though the effect of treating spontaneous intracranial hemorrhage with rFVIIa at doses ≤40 μg/kg of patient … rFVIIa) in the hospital setting has increased despite limited comparative data on its effectiveness and safety … How is it being used, and what is the evidence of benefits and harms for treated patients? … In-Hospital, Off-Label Use of rFVIIa TE Events/Total Patients (%) Risk Difference Summary Effect Size
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
    December 14, 2017 - Due to safety issues, the use of leuprolide is limited for only 3 months. … bleeding and statistically significant improvements in women’s symptom and health-related quality-of-life indicators … had much less time to get pregnant than the myomectomy patients. … US patients are different than European (or other patients) in that there is greater direct appeal by … pharma, device companies and providers to the consumer (patient).
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
    November 09, 2011 - , routine surveillance for patients at admission  Identifying patients at risk for suicide  … safety practice is applied to a patient safety problem in order to improve beneficial patient safetySafety Practice Patient Safety Problem Contexts - Safety Culture, Teamwork, Leadership … of Patient Safety Practices – Developing Criteria 3 I. … Assessing the Evidence for Context-Sensitive Effectiveness and Safety of Patient Safety Practices:
  20. effectivehealthcare-admin.ahrq.gov/products/prehospital-airway-management/research
    August 01, 2021 - EHC The Evidence-based Practice Centers The Scientific Resource Center Registry of Patient … Construct comparisons that are more clearly defined by specific emergency types, patient groups, and … No conclusion was supported by high SOE for any comparison and patient group. … 14, 2021 Systematic Review AHRQ and the National Highway Traffic SafetySafety Practices and Ratings by a Technical Expert Panel, 2023-2024 Rapid Evidence Product

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: